Charles River Laboratories International (CRL) Change in Receivables (2009 - 2025)
Charles River Laboratories International (CRL) posted quarterly Change in Receivables of -$27.6 million for Q4 2025, down 734.27% year-over-year from $4.4 million in Q4 2024, and down 3.89% on a QoQ basis from -$26.6 million in Q3 2025.
Charles River Laboratories International (CRL) Change in Receivables (2009 - 2025) Analysis & Trends
Charles River Laboratories International (CRL) has reported Change in Receivables for 17 consecutive years, with -$27.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Change in Receivables fell 734.27% year-over-year to -$27.6 million; the TTM figure through Dec 2025 stood at -$35.7 million (down 65.36% YoY), while the FY2025 annual figure was -$35.7 million, down 65.36% from the prior year.
- Change in Receivables came in at -$27.6 million for Q4 2025 at Charles River Laboratories International, down from -$26.6 million in the prior quarter.
- The five-year high for Change in Receivables was $59.7 million in Q2 2022, with the low at -$27.6 million in Q4 2025.
- Average Change in Receivables over 5 years is $7.7 million, with a median of $3.8 million recorded in 2021.
- Across the five-year window, Change in Receivables jumped 1135.05% in 2022 and plunged 734.27% in 2025, its largest moves.
- Year by year, Change in Receivables stood at -$9.0 million in 2021, then slumped by 163.41% to -$23.6 million in 2022, then declined by 8.68% to -$25.6 million in 2023, then soared by 87.09% to -$3.3 million in 2024, then slumped by 734.27% to -$27.6 million in 2025.
- According to Business Quant data, Change in Receivables over the past three periods registered -$27.6 million, -$26.6 million, and -$10.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 533.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | - |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -66.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 56.81 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 121.07 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -12.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -118.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -65.11 Mn |
| 10 | Charles River Laboratories International | 11.36 Bn | 11.15 Bn | 744.94 Mn | -27.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | -27.63 Mn |
| Dec 27, 2025 | -27.63 Mn |
| Sep 27, 2025 | -26.60 Mn |
| Sep 27, 2025 | -26.60 Mn |
| Jun 28, 2025 | -10.86 Mn |
| Jun 28, 2025 | -10.86 Mn |
| Mar 29, 2025 | 29.35 Mn |
| Mar 29, 2025 | 29.35 Mn |
| Dec 28, 2024 | -3.31 Mn |
| Dec 28, 2024 | -3.31 Mn |
| Sep 28, 2024 | -17.23 Mn |
| Sep 28, 2024 | -17.23 Mn |
| Jun 29, 2024 | -18.35 Mn |
| Jun 29, 2024 | -18.35 Mn |
| Mar 30, 2024 | 17.28 Mn |
| Mar 30, 2024 | 17.28 Mn |
| Dec 30, 2023 | -25.65 Mn |
| Dec 30, 2023 | -25.65 Mn |
| Sep 30, 2023 | 10.83 Mn |
| Sep 30, 2023 | 10.83 Mn |